Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
---|
02/21/2002 | WO2002013827A1 Process for the preparation of dinapsoline |
02/21/2002 | WO2002013824A1 Cyclopentyl modulators of chemokine receptor activity |
02/21/2002 | WO2002013802A2 Method of treating estrogen receptor positive carcinoma |
02/21/2002 | WO2002006247A8 Substituted amidoalkyl-uracils as parp inhibitors |
02/21/2002 | WO2001032631A3 Heterocyclic cytotoxic agents |
02/21/2002 | US20020022728 Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests |
02/21/2002 | US20020022636 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
02/21/2002 | US20020022635 For therapy of cancer; inflammation; an autoimmune, infectious or ocular disease; or age-related macular degeneration |
02/21/2002 | US20020022616 Azepino[4,5-b]pyrano[3,2-e]indoles |
02/21/2002 | US20020022575 Dialkyl-halogenophenyl-substituted ketoenols |
02/21/2002 | CA2418273A1 Urea compounds and methods of uses |
02/21/2002 | CA2417807A1 Process for the preparation of dinapsoline |
02/20/2002 | CN1336929A Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
02/20/2002 | CN1336924A Amide and urea derivatives as 5-HT reuptake inhibitors and at 5-HT 1B/1D ligands |
02/20/2002 | CN1336375A Spiro-and dicyclic diazine and carbozine oxazolidohne compound |
02/19/2002 | US6348597 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines |
02/19/2002 | US6348595 Perylene-3,4,9,10-tetracarboximide is hydroxymethylated by reaction with formaldehyde to form bis(hydroxymethyl) perylene-3,4,9,10-tetracarboximide; one pot process |
02/19/2002 | US6348467 Antitumor agent from animal extracts |
02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
02/14/2002 | WO2002012195A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
02/14/2002 | WO2002012188A2 Indole compounds useful for the treatment of cancer |
02/14/2002 | WO2001055119A3 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
02/14/2002 | WO2001051479A3 Tricyclic compounds with antiviral activity |
02/14/2002 | US20020019531 Indoles |
02/14/2002 | US20020019412 Antidiabetic agents |
02/14/2002 | US20020019397 Heterocycle carboxamides as antiviral agents |
02/14/2002 | US20020019390 Imidazole and imidazoline derivatives and uses thereof |
02/14/2002 | US20020019389 3-(N-(5,6-dimethyl-2-methoxypyridin-3-yl)aminocarbonyl)-7,8-dimethoxy-1-phenyl-2,3,4,5-tetrahydro-3H-benzazepine, for example |
02/14/2002 | US20020019388 (cis)-6-(3-pyridinyl)-3,6-diazabicyclo(3.2.0) heptane for example; Alzheimer's disease, Parkinson's disease, attention deficit hyperactivity disorder, depression, nicotinic withdrawal syndrome, Tourette's syndrome, and schizophrenia |
02/14/2002 | CA2419060A1 Indole compounds useful for the treatment of cancer |
02/14/2002 | CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
02/14/2002 | CA2417816A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
02/13/2002 | EP1178982A1 Heterocyclic substituted aminoazacycles useful as central nervous system agents |
02/13/2002 | EP1178973A2 Novel compounds, their use and preparation |
02/13/2002 | EP1100799B1 Preparation of camptothecin and nothapodytine derivatives |
02/13/2002 | EP1049695B1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
02/13/2002 | EP1042320B1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists |
02/13/2002 | EP0869942B1 4-((heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
02/13/2002 | EP0861236B1 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
02/13/2002 | EP0819112B1 Oxidative process for preparing narwedine derivatives |
02/13/2002 | CN1335846A Pyrano, piperidino and thiopyrano compounds and methods of use |
02/13/2002 | CN1335836A Tricyclic pyrazole derivatives |
02/13/2002 | CN1335316A New N-triazolyl methyl piperazine derivate using as neurokinin receptor antagonistic agent |
02/13/2002 | CN1335062A Fungicide composition |
02/12/2002 | US6346621 Indole or quinoline compounds substituted with amino compounds on nitrogen |
02/12/2002 | US6346618 Optical resolution of narwedine-type compounds |
02/12/2002 | US6346540 1-(1,2-disubstituted pipeidinyl)-4-substituted piperidine derivatives |
02/12/2002 | US6346536 Benzopyranoisoquinolone derivatives; neurodegenerative and brain disorders; reperfusion injuries; antiischemic agents |
02/12/2002 | CA2057504C Process for preparing new n-acyl-2,3-benzodiazepine derivatives, their acid addition salts and pharmaceutical compositions containing the same |
02/07/2002 | WO2002010164A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers |
02/07/2002 | WO2002010140A2 Imidazolyl derivatives |
02/07/2002 | WO2002010135A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
02/07/2002 | WO2001013900A3 Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
02/07/2002 | US20020016460 Pyridine -imidazole, -thiazole or -oxazole derivatives; treating autoimmune diseases, chronic inflammatory diseases, allergic diseases, transplant rejection and cancer |
02/07/2002 | US20020016355 Synthetic pathway relies upon stereospecific synthesis of oxazoline intermediate and stereoselective addition of formyl amide to oxazoline |
02/07/2002 | US20020016344 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
02/07/2002 | US20020016337 Heterocyclic analgesic compounds and methods of use thereof |
02/07/2002 | DE10036818A1 Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten New N-triazolylmethyl piperazine derivatives as neurokinin receptor antagonists |
02/07/2002 | CA2417204A1 Imidazolyl derivatives |
02/07/2002 | CA2385908A1 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers |
02/06/2002 | EP1177191A1 Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa |
02/06/2002 | EP0771198B1 Dihydro-2,3-benzodiazepine derivatives |
02/06/2002 | CN1334812A Piperazine derivatives |
02/06/2002 | CN1334806A Beta-amide and beta-sulfonamide carboxylic acid derivs., their preparation and their use as endothelin receptor antagonists |
02/06/2002 | CN1334728A Palladium-substd. bacteriochlorophll derivatives and use thereof |
01/31/2002 | WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
01/31/2002 | WO2002008224A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
01/31/2002 | WO2002008211A2 Benzothiazepines and their use as antihyperlipidemics |
01/31/2002 | US20020013460 Condensed pyridine compound |
01/31/2002 | US20020013354 p38 map kinase inhibitors |
01/31/2002 | US20020013336 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
01/31/2002 | US20020013334 HMG-CoA reductase inhibitors and method |
01/31/2002 | US20020013333 As inhibitors of matrix metalloproteinase, for therapy of diseases such as degenerative diseases and certain cancers |
01/31/2002 | US20020013310 Inhibitors of the activity of Factor Xa such as 3-((1-(4-Aminoquinolin-7-ylmethyl)-2-oxopyrrolidin-3-(R)-yl)-( 5- chloro-1H-indol-2-ylmethyl)amino)propionic acid methyl ester |
01/31/2002 | US20020012683 Cosmetic composition comprising at least one ingredient chosen from compounds of formula (1) and salts thereof, use thereof as colouring agent, and novel compounds of formulae (IIa), (IIIa), (IVa), (Va), and (VIa), and salts thereof |
01/31/2002 | DE19881732C1 New phosphodiesterase inhibiting 2-phenyl-imidazotriazinone derivatives useful for treating e.g. cardiovascular, cerebrovascular and/or urogenital diseases |
01/31/2002 | DE10034801A1 Substituierte Amidoalkyl-uracile und ihre Verwendung Substituted amidoalkyl uracils and their use |
01/31/2002 | DE10034625A1 New aryl substituted thienyl-oxazolidinone derivatives useful as tumor necrosis factor-alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, transplant rejection and psoriasis |
01/31/2002 | DE10034624A1 New aryl substituted thienyl-oxazolidinone derivatives useful as tumor necrosis facto-alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, cardiac infraction and psoriasis |
01/31/2002 | CA2417192A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
01/30/2002 | EP1176144A1 N-triazolylmethyl-piperazine derivatives as neurokinine receptor-antagonists |
01/30/2002 | EP1176140A1 Amide compounds and medicinal use thereof |
01/30/2002 | EP1175398A1 Indoline derivatives as progesterone antagonists |
01/30/2002 | CN1333774A Substituted benzofuranodindoles and indenoindoles as novel potassium channel openers |
01/30/2002 | CN1333766A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors |
01/30/2002 | CN1333764A Benzofuran derivatives, process for the preparation of the same and uses thereof |
01/30/2002 | CN1333758A Substituted bicyclic derivatives useful as anticancer agents |
01/30/2002 | CN1333753A Quinolinecarboxamides as antiviral agents |
01/29/2002 | US6342606 Method for producing pyridine derivatives |
01/29/2002 | US6342601 Treating allograft rejection, rheumatoid arthritis |
01/29/2002 | US6342516 Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
01/29/2002 | US6342459 Photochromic naphthopyrans |
01/24/2002 | WO2002006361A2 Novel photochromic polymers and methods of synthesizing same |
01/24/2002 | WO2002006247A1 Substituted amidoalkyl-uracils as parp inhibitors |
01/24/2002 | WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
01/24/2002 | WO2002005860A1 Radioligand and binding assay |
01/24/2002 | WO2002005819A1 Compounds and methods |
01/24/2002 | WO2001058875A3 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives |
01/24/2002 | WO2000053614A8 Method for producing glyco-conjugates of 20(s)-camptothecin |
01/24/2002 | US20020010206 Treating cyclooxygenase-2 mediated disorders. |